SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-082607
Filing Date
2014-11-21
Accepted
2014-11-21 08:59:13
Documents
6
Period of Report
2014-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-24826_18k.htm 8-K 44336
2 EX-4.1 a14-24826_1ex4d1.htm EX-4.1 138737
3 EX-10.1 a14-24826_1ex10d1.htm EX-10.1 394941
4 EX-10.2 a14-24826_1ex10d2.htm EX-10.2 48673
5 EX-99.1 a14-24826_1ex99d1.htm EX-99.1 14447
6 GRAPHIC g248261moi001.jpg GRAPHIC 4687
  Complete submission text file 0001104659-14-082607.txt   649256
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 141241184
SIC: 2836 Biological Products, (No Diagnostic Substances)